RSCI 606 Regulation of Emerging Technologies and Biological Products
Units: 3 Policies, testing and regulatory requirements affecting commercialization of biologics and novel medical technologies. Focus on biologics, blood and tissue products, radiopharmaceuticals and nanotechnology. Instruction Mode: Lecture Grading Option: Letter
You must be logged in to post a comment.